Real world effectiveness of lipid-lowering medication in Denmark

被引：0
|
作者：
Jensen, Camilla B. [1 ]
Hoe, Jakob Kronkvist [2 ]
Hansen, Susanne [3 ]
Olsen, Rasmus Huan [4 ]
Johansen, Tina [5 ]
Jimenez-Solem, Espen [6 ]
Petersen, Janne [7 ,8 ]
机构：
[1] Bispebjerg & Frederiksberg Hosp, Copenhagen Phase IV Unit, Copenhagen, Denmark
[2] Phase4CPH, Copenhagen, Denmark
[3] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Copenhagen, Denmark
[4] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Phase4CPH, Copenhagen, Denmark
[5] Novartis Healthcare AS, Copenhagen, Denmark
[6] Bispebjerg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark
[7] Copenhagen Univ Hosp, Copenhagen Phase IV unit, Dept Clin Pharmacol, Copenhagen, Denmark
[8] Copenhagen Univ Hosp, Ctr Clin Res & Prevent, Copenhagen, Denmark
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
746
引用
收藏
页码：342 / 343
页数：2
相关论文
共 50 条
  • [21] Effectiveness of lipid-lowering therapy in primary care in France
    Van Ganse, E
    Moulin, P
    Bertrand, M
    Souchet, T
    Pietri, G
    de Pouvourville, G
    VALUE IN HEALTH, 2004, 7 (03) : 319 - 320
  • [22] EFFECTIVENESS OF LIPID-LOWERING DRUGS IN AN INDIGENT CARE SETTING
    CONEY, RD
    JACOBSON, T
    CIRCULATION, 1994, 90 (04) : 533 - 533
  • [23] Effectiveness of lipid-lowering therapy in primary care in France
    van Ganse, E
    Moulin, P
    Bertrand, M
    Souchet, T
    Pietri, G
    Alemao, E
    Yin, D
    de Pouvourville, G
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 155 - 155
  • [24] Cochrane corner: interventions to improve adherence to lipid-lowering medication
    van Driel, Mieke L.
    Morledge, Michael D.
    Ulep, Robin
    Shaffer, Johnathon P.
    Davies, Philippa
    Deichmann, Richard
    HEART, 2018, 104 (05) : 367 - 369
  • [25] LIPID-LOWERING MEDICATION USE BY PRIMARY-CARE PHYSICIANS
    KEYSERLING, TC
    METCALF, PA
    DAVIS, CE
    AMMERMAN, AS
    SIMPSON, RJ
    CIRCULATION, 1993, 88 (04) : 635 - 635
  • [26] Real-World Effectiveness of Lipid-Lowering Medications on Outcomes after Stroke: Potential Implications of the New-User Design
    Olaiya, Muideen T.
    Andrew, Nadine E.
    Dalli, Lachlan L.
    Ung, David
    Kim, Joosup
    Cadilhac, Dominique A.
    Wood, Peter
    May, Janet
    Clissold, Ben
    Kilkenny, Monique F.
    PRECISE investigators
    NEUROEPIDEMIOLOGY, 2022, 56 (05) : 365 - 372
  • [27] Cost-effectiveness of lipid-lowering treatment according to lipid level
    Pilote, L
    Ho, V
    Lavoie, F
    Coupal, L
    Zowall, H
    Grover, SA
    CANADIAN JOURNAL OF CARDIOLOGY, 2005, 21 (08) : 681 - 687
  • [28] Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting
    Cziraky, Mark J.
    Willey, Vincent J.
    McKenney, James M.
    Kamat, Siddhesh A.
    Fisher, Maxine D.
    Guyton, John R.
    Jacobson, Terry A.
    Davidson, Michael H.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (02) : 102 - 108
  • [29] TRENDS IN DISCONTINUATION OF LIPID-LOWERING AND ANTIHYPERTENSIVE THERAPIES: A REAL-WORLD DATA ANALYSIS IN ITALY
    Dovizio, M.
    Perrone, V
    Iacolare, B.
    Andretta, M.
    Bacca, M.
    Barbieri, A.
    Bartolini, F.
    Cavaliere, A.
    Chinellato, A.
    Ciaccia, A.
    Cillo, M. R.
    Costantini, A.
    Dell'Orco, S.
    Ferrante, F.
    Gentile, S.
    Grego, S.
    Lavalle, A.
    Maccio, S.
    Mancini, D.
    Moscogiuri, R.
    Mosele, E.
    Pagliaro, R.
    Pastorello, M.
    Procacci, C.
    Re, D.
    Santoleri, F.
    Ubertazzo, L.
    Vercellone, A.
    Degli Esposti, L.
    VALUE IN HEALTH, 2022, 25 (12) : S285 - S285
  • [30] Real-World Patient Profiles and Lipid-Lowering Efficacy of PCSK9 Inhibitors
    Ma, Tiantian
    Huang, Fengmei
    Yu, Qiuyan
    Chui, Celine S. L.
    Chen, Peiling
    Wong, Ian Chi Kei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 232 - 233
12345